OptimizeRx Corporation
As of Oct 22, 2026, OptimizeRx is in Stage 2, the uptrend phase, now in week 3 (since Oct 7, 2026). It closed at $9.08, 58.1% below its 52-week high and above its 200-day average, which is falling.
OptimizeRx Corporation operates as a digital healthcare technology company. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 16 in Health Information Services · #1 of 272 in Health Care
Is OPRX early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
OPRX among Health Information Services28th of 41 by relative strength
All 41 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | AMWL | Stage 2 · wk 25 | 97 | +7.4% |
| 2 | HNGE | Stage 2 · wk 20 | 96 | +19.1% |
| 3 | BTSG | Stage 3 · wk 8 | 94 | +9.1% |
| 4 | NRC | Stage 3 · wk 4 | 93 | −0.1% |
| 5 | SOPH | Stage 2 · wk 24 | 91 | −12.7% |
| 6 | HTFL | Stage 2 · wk 10 | 87 | +17.0% |
| 7 | HSTM | Stage 2 · wk 17 | 77 | +20.3% |
| 8 | OMCL | Stage 4 · wk 10 | 70 | +12.5% |
| …28 | OPRX | Stage 2 · wk 3 | 22 | +19.5% |
OptimizeRx: quick answers
What stage is OptimizeRx in?
As of Oct 22, 2026, OptimizeRx (OPRX) is in Stage 2, the uptrend phase. It entered Stage 2 on Oct 7, 2026 and is in week 3. What the four stages mean
Is OptimizeRx in an uptrend?
Yes. OptimizeRx is in a Stage 2 uptrend. It trades 22.3% above its 200-day average, which is falling.
How far is OptimizeRx from its 52-week high?
OptimizeRx closed at $9.08 on Oct 22, 2026, 58.1% below its 52-week high of $21.68. Its 52-week low is $4.54.
How has OptimizeRx performed over the past year?
As of Oct 22, 2026, OptimizeRx is down 54.2% over the past year and down 26.9% so far in 2026.
Which sector and industry is OptimizeRx in?
OptimizeRx is in the Health Information Services industry, part of the Health Care sector.
About this companyHealth Care· Health Information Services
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.